<DOC>
	<DOCNO>NCT02338830</DOCNO>
	<brief_summary>To evaluate value vaginal progesterone therapy reduction preterm labor asymptomatic twin pregnancy sonographic short cervix</brief_summary>
	<brief_title>Vaginal Progesterone Prevention Preterm Labor Asymptomatic Twin Pregnancies With Sonographic Short Cervix</brief_title>
	<detailed_description>Women twin pregnancy transvaginal sonographic cervical length 20-25 mm 20-24 week gestational age without symptom , sign risk factor preterm labor include study . All woman randomly divide two group ; one group ( study group ) receive vaginal progesterone suppository dose 400 mg daily begin 20-24 week gestational age ( study group ) group receive treatment ( control group )</detailed_description>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Women pregnant dichorionic twin . Transvaginal sonographic cervical length 2025 mm 2024 week gestational age . No symptom , sign risk factor preterm labor . Age &lt; 20 year &gt; 35 year . Known allergy contraindication ( relative absolute ) progesterone therapy . Pregnancy vitro fertilization ( IVF ) / intracytoplasmic sperm injection ( ICSI ) . Monochorionic twin . Known major fetal structural chromosomal abnormality . Intrauterine death one fetus death fetus . Fetal reduction current pregnancy . Cervical cerclage current pregnancy . Medical condition may lead preterm delivery . Rupture membrane . Vaginal bleeding .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Twins</keyword>
	<keyword>Preterm labor</keyword>
	<keyword>Progesterone</keyword>
	<keyword>Short cervix</keyword>
</DOC>